Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Revisão |
| Lenguaje: | inglés |
| Publicado: |
2020
|
| Acceso en línea: | https://doi.org/10.1080/14737159.2020.1768849 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|